Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F5ZGJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $76,213
Award facts
- Contract value 100% obligated
- $76,212.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $76,212.76 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on November 3, 2025, with completion expected by November 4, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside transaction for pharmaceutical products to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. The award demonstrates AmerisourceBergen Drug Corp's capability to meet federal procurement requirements through open competition and reflects the company's role as a key supplier within the DLA's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F5ZGJ?
SPE2DR26F5ZGJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26F5ZGJ worth?
The government has obligated $76,213 on SPE2DR26F5ZGJ.
Is contract SPE2DR26F5ZGJ an order under another contract?
Yes. SPE2DR26F5ZGJ is a delivery order under SPE2DR25D2109, an indefinite delivery contract.
Was contract SPE2DR26F5ZGJ competed?
The extent of competition for SPE2DR26F5ZGJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award